Quality evaluation of diagnosis and treatment guidelines and expert consensus for children with immune thrombocytopenic purpura

XING Yaping; DING Ying; HAN Shanshan; XING Wenchao; JIA Lu; TONG Min; REN Xiaodan

doi:10.6039/j.issn.1001-0408.2025.13.20

您当前的位置：

首页 >

文章列表页 >

Quality evaluation of diagnosis and treatment guidelines and expert consensus for children with immune thrombocytopenic purpura

更新时间：2025-09-24

- Quality evaluation of diagnosis and treatment guidelines and expert consensus for children with immune thrombocytopenic purpura
- ZHONGGUO YAOFANG Vol. 36, Issue 13, Pages: 1671-1676(2025)
- 作者机构：
  
  1.河南中医药大学第一附属医院儿科医院肾病紫癜诊疗中心，郑州　450003
  2.河南中医药大学儿科医学院，郑州　450046
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.13.20
  CLC： R725.5;R967
- Received：13 December 2024，
  
  Revised：2025-05-22，
  
  Accepted：23 May 2025，
  
  Published：15 July 2025
- 稿件说明：
移动端阅览
邢亚萍,丁樱,韩姗姗,等.儿童免疫性血小板减少性紫癜诊疗指南和专家共识的质量评价[J].中国药房,2025,36(13):1671-1676.

XING Yaping,DING Ying,HAN Shanshan,et al.Quality evaluation of diagnosis and treatment guidelines and expert consensus for children with immune thrombocytopenic purpura[J].ZHONGGUO YAOFANG,2025,36(13):1671-1676.
邢亚萍,丁樱,韩姗姗,等.儿童免疫性血小板减少性紫癜诊疗指南和专家共识的质量评价[J].中国药房,2025,36(13):1671-1676. DOI： 10.6039/j.issn.1001-0408.2025.13.20.

XING Yaping,DING Ying,HAN Shanshan,et al.Quality evaluation of diagnosis and treatment guidelines and expert consensus for children with immune thrombocytopenic purpura[J].ZHONGGUO YAOFANG,2025,36(13):1671-1676. DOI： 10.6039/j.issn.1001-0408.2025.13.20.

摘要

目的

对国内外发布的儿童免疫性血小板减少性紫癜（ITP）诊疗指南和专家共识的质量进行评价，以期为临床实践及今后诊疗指南/专家共识的制订和完善提供参考。

方法

系统检索PubMed、Cochrane Library、Embase、中国知网、万方数据知识服务平台、维普网、中国生物医学文献数据库，同时补充检索医脉通、中华医学会、英国国家卫生与临床优化研究所等网站；检索时间限定自建库至2024年9月2日。由经过系统培训的研究者采用指南研究与评价工具（第2版）（AGREE Ⅱ）和国际实践指南报告标准（RIGHT）独立对纳入诊疗指南/专家共识的方法学及报告质量进行评价。

结果

共纳入诊疗指南/专家共识11篇。AGREE Ⅱ工具6个领域的平均得分依次为“范围和目的”[（66.67±17.98）%

]

、“参与人员”[58.33%（13.89%，73.61%）

]

、“严谨性”[（41.81±23.85）%

]

、“清晰性”[（69.57±19.35）%

]

、“应用性”[（35.98±17.83）%

]

、“独立性”[27.08%（0，75.00%）

]

；11篇文献中9篇推荐等级为B级，2篇推荐等级为C级，无A级文献。RIGHT工具7个领域的平均报告率分别为“基本信息”[（72.35±12.95）%

]

、“背景”[（54.55±15.40）%

]

、“证据”[（36.36±24.81）%

]

、“推荐意见”[（53.25±19.20）%

]

、“评审和质量保证”[0（0，25.00%）

]

、“资金与利益冲突声明及管理”[12.50%（0，25.00%）

]

及“其他”[8.33%（0，50.00%）

]

。诊疗指南与专家共识在AGREE Ⅱ和RIGHT评分上的差异无统计学意义（

＞0.05）。

结论

纳入的诊疗指南和专家共识整体质量不高，推荐等级为B级或C级，建议临床决策优先参考其中相对高质量的诊疗指南/专家共识；现有的儿童ITP中医药诊疗指南的证据质量有待提高，且尚无中西医结合诊疗指南/专家共识。建议按照AGREE Ⅱ和RIGHT各领域要求修改或撰写相关诊疗指南/专家共识以指导临床实践。

Abstract

OBJECTIVE

To evaluate the quality of diagnosis and treatment guidelines and expert consensuses on childhood immune thrombocytopenic purpura （ITP） published domestically and internationally， in order to provide reference for clinical practice and future guideline/expert consensus development and improvement.

METHODS

A systematic search was conducted across multiple databases， including PubMed， Cochrane Library， Embase， CNKI， Wanfang data， VIP， CBM； additionally， supplementary searches were carried out on websites such as Medlive， the Chinese Medical Association’s official website， and National Institute for Health and Clinical Excellence in the UK. The retrieval time ranged from the inception to September 2， 2024. Researchers who had undergone systematic training independently evaluated the methodology and report quality included in the guideline/consensus using the Appraisal of Guidelines Research and Evaluation Ⅱ （AGREE Ⅱ） and the Reporting Items for Practice Guidelines in Healthcare （RIGHT）.

RESULTS

A total of 11 guidelines/consensuses were included. The average scores for the six domains of AGREE Ⅱ tool respectively were “range and purpose” [（66.67±17.98）%

]

， “participants” [58.33%（13.89%，73.61%）

]

， “rigor” [（41.81±23.85）%

]

， “clarity” [（69.57±19.35）%

]

， “applicability” [（35.98±17.83）%

]

， and “independence” [27.08% （0，75.00%）

]

； out of 11 articles， 9 had a recommendation level of B， 2 had a recommendation level of C， and there were no A-level articles. The average reporting rates of the 7 areas in the RIGHT tool were “basic information” [（72.35±12.95）%

]

， “background” [（54.55±15.40）%

]

， “evidence” [（36.36±24.81）%

]

， “recommended opinions” [（53.25±19.20）%

]

， “review and quality assurance” [0 （0， 25.00%）

]

， “funding and conflict of interest statement and management” [12.50%（0，25.00%）

]

， and other aspects [8.33%（0， 50.00%）

]

. In addition， there was no statistically significant difference in the AGREE Ⅱ and RIGHT scores between the guidelines and consensuses （

＞0.05）.

CONCLUSIONS

The overall quality of the guidelines and consensuses included in this study is not high， with a recommended level of B or C. It is recommended that clinical decision-making prioritize referring to the relatively high-quality guideline/consensus among them. The quality of evidence in the existing traditional Chinese medicine guidelines for children with ITP needs to be improved， and there is no integrated guideline/consensus for traditional Chinese and Western medicine. It is recommended to revise or write relevant guideline/consensus according to the requirements of AGREE Ⅱ and RIGHT in various fields to guide clinical practice.

关键词

Keywords

references

万勃，尉耘翠，曹旺，等 . 艾曲泊帕治疗儿童免疫性血小板减少症的临床综合评价 [J ] . 实用药物与临床， 2024 ， 27 （ 2 ）： 91 - 96 .

中国儿童原发性免疫性血小板减少症诊断与治疗指南改编工作组，中华医学会儿科学分会血液学组，中华儿科杂志编辑委员会，等 . 中国儿童原发性免疫性血小板减少症诊断与治疗改编指南： 2021版 [J ] . 中华儿科杂志， 2021 ， 59 （ 10 ）： 810 - 819 .

王丽媛，刘亢亢，储金华，等 . 儿童免疫性血小板减少症病程慢性化影响因素的研究 [J ] . 中国实验血液学杂志， 2021 ， 29 （ 3 ）： 881 - 886 .

JHINGAN A ， GOEL N ， SINGH A ， et al . Efficacy of short-course high-dose oral prednisolone in rapid platelet reco- very for pediatric acute immune thrombocytopenic Purpura ：a prospective cohort study [J ] . J Hematol ， 2025 ， 14 （ 3 ）： 133 - 138 .

THAKRE R ， GHARDE P ， RAGHUWANSHI M . Idiopathic thrombocytopenic Purpura ：current limitations and management [J ] . Cureus ， 2023 ， 15 （ 11 ）： e49313 .

TAKASE K ， NAGAI H ， KADONO M ， et al . High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic Purpura [J ] . Int J Hematol ， 2020 ， 111 （ 3 ）： 388 - 395 .

胡美薇，杨阳，陈春梅，等 . 基于巨噬细胞极化研究加味黄芪建中汤治疗糖皮质激素耐药或复发免疫性血小板减少症作用机制 [J ] . 中药药理与临床， 2025 ， 41 （ 1 ）： 110 - 116 .

李润杰，李萌，倪润丰，等 . 中西医结合治疗原发免疫性血小板减少症的系统评价及Meta分析 [J ] . 天津中医药大学学报， 2023 ， 42 （ 6 ）： 714 - 724 .

BROUWERS M C ， KHO M E ， BROWMAN G P ， et al . AGREE Ⅱ：advancing guideline development，reporting and evaluation in health care [J ] . CMAJ ， 2010 ， 182 （ 18 ）： 839 - 842 .

CHEN Y ， YANG K ， MARUŠIC A ， et al . A reporting tool for practice guidelines in health care：the RIGHT statement [J ] . Ann Intern Med ， 2017 ， 166 （ 2 ）： 128 - 132 .

归舸，蒋璐灿，张伶俐，等 . 全球现有儿童特发性血小板减少性紫癜指南的循证评价 [J ] . 中国药房， 2018 ， 29 （ 4 ）： 541 - 546 .

JIANG M ， GUAN W J ， FANG Z F ， et al . A critical review of the quality of cough clinical practice guidelines [J ] . Chest ， 2016 ， 150 （ 4 ）： 777 - 788 .

戴启刚，余惠平，宋建芳 . 中医儿科临床诊疗指南：小儿免疫性血小板减少症：制订 [J ] . 中医儿科杂志， 2016 ， 12 （ 4 ）： 1 - 5 .

中华医学会儿科学分会血液学组，《中华儿科杂志》编辑委员会 . 儿童原发性免疫性血小板减少症诊疗建议 [J ] . 中华儿科杂志， 2013 ， 51 （ 5 ）： 382 - 384 .

国家卫生健康委 . 儿童原发性免疫性血小板减少症诊疗规范：2019年版 [J ] . 全科医学临床与教育， 2019 ， 17 （ 12 ）： 1059 - 1062 .

British Committee for Standards in Haematology General Haematology Task Force . Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults，children and in pregnancy [J ] . Br J Haematol ， 2003 ， 120 （ 4 ）： 574 - 596 .

DE MATTIA D ， DEL VECCHIO G C ， RUSSO G ， et al . Management of chronic childhood immune thrombocytopenic purpura：AIEOP consensus guidelines [J ] . Acta Haematol ， 2010 ， 123 （ 2 ）： 96 - 109 .

NEUNERT C ， TERRELL D R ， ARNOLD D M ， et al . American Society of Hematology 2019 guidelines for immune thrombocytopenia [J ] . Blood Adv ， 2019 ， 3 （ 23 ）： 3829 - 3866 .

SHIRAHATA A ， ISHII E ， EGUCHI H ， et al . Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura [J ] . Int J Hematol ， 2006 ， 83 （ 1 ）： 29 - 38 .

EBERL W ， DICKERHOFF R ， Pediatric Committee of Society of Thrombosis and Hemostasis Research . Newly diagnosed immune thrombozytopenia：German guideline concerning initial diagnosis and therapy [J ] . Klin Padiatr ， 2012 ， 224 （ 3 ）： 207 - 210 .

PROVAN D ， ARNOLD D M ， BUSSEL J B ， et al . Updated international consensus report on the investigation and management of primary immune thrombocytopenia [J ] . Blood Adv ， 2019 ， 3 （ 22 ）： 3780 - 3817 .

RUSSO G ， PARODI E ， FARRUGGIA P ， et al . Recommendations for the management of acute immune thrombocytopenia in children. A consensus conference from the Italian Association of Pediatric Hematology and Oncology [J ] . Blood Transfus ， 2024 ， 22 （ 3 ）： 253 - 265 .

张培钰，陈丹青 . 某医院门急诊儿童中成药处方分析 [J ] . 中医药管理杂志， 2022 ， 30 （ 17 ）： 117 - 119 .

熊婷婷，王飞 . 四川省妇幼保健院儿童中成药临床应用分析 [J ] . 中药与临床， 2025 ， 16 （ 2 ）： 46 - 48，51 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Quality evaluation of Euscaphis japonica from different habitats using chemometrics combined with weighted TOPSIS model

Comprehensive evaluation of the quality of Yindan huoxue tongyu granules based on fingerprint combined with content of pharmacodynamic components

Optimization of particle forming process and quality evaluation of Yindan huoxue tongyu granules

Study on quality evaluation of Mongolian medicine Sanzi powder： fingerprint， chemical pattern recognition and multi-component quantification analysis

Quality evaluation of Jingtian granule based on fingerprint combined with chemical pattern recognition

Related Author

GAO Yuqiu

ZHENG Shuai

YU Xue

ZOU Guihua

ZHANG Kai

BAI Shuxian

WANG Dandan

WU Zuomin

Related Institution

College of Pharmacy， Mudanjiang Medical University

First Clinical Medical College， Mudanjiang Medical University

Dept. of Pharmacy， Hongqi Hospital Affiliated to Mudanjiang Medical University

Dept. of Critical Care Medicine， Luohe Central Hospital

Dept. of Pharmacy， Luohe Central Hospital

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰